Detalhe da pesquisa
1.
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.
Ann Oncol
; 30(5): 757-765, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865223